Medtronic Minimed, Inc.

Advanced Bionics Corporation

Second Sight Medical Products, Inc.

Alfred E. Mann Foundation for Scientific Research

Incumed, Inc.

Boston Scientific Neuromodulation Corporation

Minimed, Inc.

Pacesetter Infusion, Ltd.

Other

Advanced Bionics Ag

Pacesetter Systems Inc.

Alfred E. Mann Foundation

Medical Research Products-b, Inc.

Perqflo, LLC

Alfred E Mann

John Livingston

Jay A Yonemoto

Luis J Malave

Deborah Ruppert

Dennis P Bishop

Alan Haubach

James D Causey, Iii

Chad Srisathapat

Bob Murtfeldt

Adrian Gut

Cliff Hague

Joseph H Schulman

Tom Xiaohai He

Robert Jay Greenberg

Neil Hamilton Talbot

Jerry Ok

Clifford W Hague

John Joseph Mastrototaro

Ronald J Lebel

James Singleton Little

Janusz A Kuzma

Brian V Mech

James Causey

James L Henke

Richard E Purvis

Peter Hong

Karl-Heinz Ihrig

DaoMin Zhou

Brad T Hite

James P McGivern

Joseph Y Lucisano

David I Whitmoyer

Byron L Moran

Albert A Maltan

Dau Min Zhou

Thomas H R Lenarz

Gaillard R Nolan

Philip H Lee

Orville Rey Rule, Iii

Todd K Whitehurst

Michael Allen Faltys

Charles L Byers

William Vanbrooks Harrison

Peter C Lord

Michael A Moffitt

Rafael Carbunaru

William P Van Antwerp

John Charles Gord

Matthew Isaac Haller

George Tziviskos

Dao Min Zhou

Jack W Love

Clyde K Nason

Abram D Janis

Yitzhak Zilberman

Chalirmkiert Srisathapat

Robert Dan Dell

Thomas J Balkany

Susan M McConnell

Paul Kaluzniak

Tom J Law

James W Beazell

William H Slattery, Iii

Peter K Johnson

Rolf-Dieter Battmer

Hiwa Nezhadian

Albert S Maltan

Magdi F Habib

Robert A Schindler

Gailland R Nolan

H Lee Renger

Causey D James

John H Livingston

Robert Murtfeldt

James D Iii Causey

Robert Murfeldt

James D Causey Iii

An infusion system for infusing a liquid into a body includes an external infusion device and a remote commander. The external infusion device includes a housing, a receiver, a processor and an indication device. The receiver is coupled to the housing and for receiving remotely generated commands. The processor is coupled to the housing and the receiver to receive remotely generated commands and to control the external infusion device in accordance with the commands. The indication device indicates when a command has been received and indicates when the command is being utilized to control the external infusion device so that the external infusion device is capable of being concealed from view when being remotely commanded. The remote commander includes a commander housing, a keypad for transmitting commands, and a transmitter for transmitting commands to the receiver of the external infusion device.

External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities

The invention is directed to a method of bonding a hermetically sealed electronics package to an electrode or a flexible circuit and the resulting electronics package that is suitable for implantation in living tissue, for a retinal or cortical electrode array to enable restoration of sight to certain non-sighted individuals. The hermetically sealed electronics package is directly bonded to the flex circuit or electrode by electroplating a biocompatible material, such as platinum or gold, effectively forming a plated rivet-shaped connection, which bonds the flex circuit to the electronics package. The resulting electronic device is biocompatible and is suitable for long-term implantation in living tissue.

Biocompatible bonding method and electronics package suitable for implantation

Novel multilayer composite material vias for biological implants are disclosed. The vias comprise two metals, so that the metal more compatible with biological environments is on one end of the via, and the metal more compatible with fabrication of a hermetic package is on the other end of the via.

Multilayer composite materials vias

This invention is a retinal electrode array assembly and methods of using the same that facilitate surgical implant procedures by providing the operating surgeon with visual references and grasping means and with innovations that reduce actual and potential damage to the retina and the surrounding tissue.

Implantable retinal electrode array configuration for minimal retinal damage and method of reducing retinal stress

Apparatus, for use with a fluid cartridge, that include a percutaneous port having an interior configured to receive the fluid cartridge, an implantable operative portion that has a fluid transfer device with an inlet and an outlet, and delivery/manifold tube with a manifold portion and a delivery portion, are disclosed.

Partially implantable medical devices and delivery/manifold tube for use with same

Apparatus having a percutaneous cartridge port with an exterior having a porous region configured to promote soft tissue ingrowth and an implantable operative portion, including a fluid transfer device, operably connected to the percutaneous cartridge port, and methods that may be associated with an apparatus having a percutaneous cartridge port.

Partially implantable medical devices and methods

Fluid and power cartridges, including a housing with at least one side wall and an end wall, a needle, a power source carried by the housing and positive and negative power contacts associated with the housing and operably connected to the power source, and apparatus including such fluid and power cartridges.

Fluid cartridges including a power source and partially implantable medical devices for use with same

An implantable neurostimulation system includes both implantable and external components. Electrical connectivity between the external and implanted components is achieved through a plurality of feedthrough pins located within an insulative wall of a percutaneous port embedded in the skin. The percutaneous port has the general shape and appearance of a small thimble, embedded in the skin with its open end facing outwardly from the skin surface, and with its closed end located below the skin surface, thereby forming a cavity or dimple in the skin. Various plugs or cartridges can be removably inserted into the cavity of the percutaneous port, in various orientations, to facilitate appropriate connectivity between the external and implanted components of the system through selected ones of the feedthrough pins. A mesh edging secured around the periphery wall of the port promotes tissue ingrowth and vascularization, thereby forming a percutaneous seal around the port that prevents infection.

Neural stimulator with percutaneous connectivity

A method and apparatus for reducing the incident of infection proximate to an exit site where a prosthesis fastener, e.g., a bone screw, percutaneously penetrates a patient's skin/soft tissue. Infection reduction is achieved in accordance with the invention by growing a tissue integrating seal around the fastener proximate to the exit site.

Prosthesis attachment method and apparatus with soft tissue integrating seal

An implantable stimulator includes a tube assembly that is configured to house a number of components that are configured to apply at least one stimulus to at least one stimulation site within a patient. The tube assembly has a shape that allows the stimulator to be implanted within said patient in a pre-determined orientation. Exemplary methods of stimulating a stimulation site within a patient include applying an electrical stimulation current to a stimulation site via one or more electrodes extending along one or more sides of a stimulator. The stimulator has a shape allowing the stimulator to be implanted within the patient in a pre-determined orientation.

Implantable stimulator

A percutaneous cochlear implant system includes a cochlear stimulator configured to be coupled to an electrode lead, the electrode lead comprising a plurality of electrodes configured to be in communication with a plurality of stimulation sites within a cochlear region of a patient, a sound processor communicatively coupled to the cochlear stimulator and configured to control the cochlear stimulator to generate and apply electrical stimuli representative of an audio signal to at least one of the stimulation sites via at least one of the electrodes, a power source configured to provide power to at least one of the cochlear stimulator and the sound processor, and a percutaneous port configured to be percutaneously implanted within a head of the patient. The percutaneous port may be configured to house at least one of the power source, sound processor, and cochlear stimulator. Additionally or alternatively, the percutaneous port is configured to facilitate programming, recharging of a rechargeable power source (e.g., implanted battery), control of, and/or access to at least one of the power source, sound processor, and cochlear stimulator.

Percutaneous cochlear implant systems and methods

Growing community of inventors

Beverly Hills, CA, United States of America

Alfred E Mann